FCMI
JNCE

Foresite Capital Management III’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Foresite Capital Management III’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-91,600
Closed -$2.01M – 32
2017
Q1 		$2.01M Buy
+91,600
New +$2.01M 0.77% 20